ft 10 sep 93 glaxo increas dividend 29 glaxo europ largest pharmaceut group yesterday report 17 per cent rise pre tax profit year june 30 pound 1 42bn pound 1 67bn result help robust perform zantac world best sell medicin recent introduc product advantag exchang rate contribut improv glaxo board surpris market 29 per cent dividend increas propos final dividend 15p make total 22p 17p year glaxo share rose 27p 628p glaxo cash mountain continu grow liquid fund avail invest increas pound 1 332bn pound 1 815bn howev mr john coomb financ director said view uncertain condit healthcar environ compani hurri spend dr richard syke chief execut said doubt remain futur zantac sale rose 20 per cent pound 2 172bn constant exchang rate growth 11 per cent drug patent challeng face increas competit dr syke said expect us healthcar reform signific impact glaxo busi compani gener dollar 3bn pound 1 9bn us nearli half alreadi manag care system presid bill clinton hope encourag dr syke said expenditur research develop increas 24 per cent pound 739m make group world largest spender drug r amp compani said expect r amp spend increas pound 850m come year capit expenditur pound 650m 15 per cent probabl peak dr syke said group turnov increas 20 per cent pound 4bn pound 4 9bn oper profit 18 per cent pound 1 28bn pound 1 525bn constant exchang rate rose 11 per cent 12 per cent respect earn per share increas 16 per cent 34 3p 39 9p earn per american depositari receipt increas 7 per cent dollar 1 21 dollar 1 29 background page 22 lex page 20